Coca-Cola launched the soda brand in the 1990s to compete with Mountain Dew. Sales didn't exactly take off.
VIDEO ON MSN MONEY
U.S. clearance is a major milestone, but Bydureon faces stiff competition from its fast-selling rival.
Shares of Amylin Pharmaceuticals (AMLN) climbed Monday after the biotech company won U.S. approval of its Bydureon diabetes drug.
Amylin shares rose over 17% to close at $14.26. The company's development partner, Alkermes (ALKS), didn't fare as well, ending the day slightly down.
Global fundamentals suggest that this will not be a repeat of 2011's flame-out.
A year ago, we took off like a bat out of hell, and then we ran smack into what can only be called a bear market. We had the industrials crater, the banks give it up and the oils get crushed because of European woes, the latter being a total oddity, because oil never came in. The techs were awful, led by a faltering semiconductor group with a contagion that spread everywhere except for Apple (AAPL).
Once again, we have taken off with great gusto, the best rally since 1997, and it has been across the board, with the financials and techs leading the way and the industrials, such as Caterpillar (CAT) and Honeywell (HON), not that far behind.
A substantial number of subscribers are shifting from hybrid service to streaming only.
The earnings highlighted a couple of things -- Netflix is back on growth track and DVD subscribers continue to decline substantially. A little confusing? The point is that customers are not leaving Netflix as much as before and a substantial decline is coming from subscribers dropping hybrid service and moving to streaming only.
The world's leading aluminum producer is focusing on building high-quality engineered products that boost margins.
Consequently, the market has been quite harsh on the company's stock, pushing it down into single digits.
These master limited partnerships offer an average yield of 5.6%.
In my view, master limited partnerships (MLPs) are probably the best hedge against rising energy prices.
Three favorites are Penn Virginia Resource Partners (PVR), ONEOK Partners (OKS), and Plains All American Pipeline (PAA).
BlackRock says fast-growing economies could decouple as the developed world struggles, but a global recession is still possible.
Do you feel lucky this year?
If so, you might want to bet on the optimistic side of the theoretical coin toss that the strategy team at BlackRock Investment Institute proposed in its investment outlook analysis, The Year of Living Divergently.
Commercial aviation business wins new orders, while defense business looks resilient despite US government cuts.
Boeing tackled the uncertainties of global economic growth, defense budget pressures and contraction in cargo volumes in an admirable way.
A Fox reporter says the social network is furious over Morgan Stanley's claims of trumping Goldman Sachs as the lead underwriter.
According to Fox business reporter Charlie Gasparino, Facebook is upset that the bank was allegedly blabbing that it was close to securing the lead underwriting role in the social network's much-anticipated IPO, a spot that many pundits figured would go to rival Goldman Sachs (GS). Gasparino isn't revealing his source, and a spokesman for Morgan Stanley couldn't be be reached.
Goldman upgrades Citigroup and Morgan Stanley but downgrades Bank of America and JP Morgan.
Monday's noteworthy upgrades include:
- Citigroup (C) upgraded to Buy from Neutral at Goldman
- Morgan Stanley (MS) upgraded to Conviction Buy from Neutral at Goldman
- Zimmer (ZMH) upgraded to Overweight from Neutral at Piper Jaffray
- AutoZone (AZO) upgraded to Neutral from Sell at Goldman
- Microsoft (MSFT) upgraded to Overweight from Neutral at Atlantic Equities
- Regeneron (REGN) upgraded to Buy from Neutral at BofA/Merrill
- Motorola Solutions (MSI) upgraded to Buy from Hold at Argus
For these supermarket giants, paying more attention to prices would better support stock valuations -- if it's not too late.
By Ronald Thomas, CFA
I have always thought that too many investment analysts, at least where the consumer sector is concerned, do not pay enough attention to marketing and marketing strategy, and spend too much time playing with financial ratios. Many analysts overlook the relative prices companies charge consumers versus their competitors. They then do not sound an alarm for potential future market share losses and the effect that will have on stock valuations. In the food retailing area, Safeway (SWY) and SurperValu (SVU) are examples.
The maker of Enfamil was cleared in a recent health scare, but it may be too late to prevent other pressures from biting at the stock.
By Jim Jubak
Mead Johnson Nutrition (MJN) on Thursday reported fourth-quarter earnings of 52 cents a share, a penny above Wall Street estimates, and revenue of $911.3 million, above the Wall Street consensus of $894.04 million.
On the news, the stock closed up at $74.01. That $74 a share was the price I set for an exit in the aftermath of the death of a baby in Missouri that had consumed the company's Enfamil baby formula from a Cronobacter infection.
To me, the stock is now a sell.
One analyst makes a case for boosting the stock's price target to $650.
Apple (AAPL) has returned to its winning ways, reporting that it had more than doubled its profit and totally blowing away sales expectations for its iPhone and iPad and its Mac computers.
Revenue surged by 73% year over year. It was an absolute monster quarter. The results easily outdistanced the already heady expectations for holiday sales. The company sold 37.04 million iPhones worldwide, up 128% from a year ago. It sold 15.43 million iPads, 111% better than the year-earlier period.
Down the road, you'll find it's worth the price.
Ralph Lauren (RL), the iconic luxury brand with a host of top-flight apparel, has spent decades as a mainstay in high-end retail.
As it turns out, it's a spiffy stock, too.
RL shares are up 40% in the last year and have tripled since 2009 thanks to steady growth. The company's fiscal 2011 earnings of $568 million, or $5.75 per share, were up almost 20% from the year before -- on top of 20% growth in both 2009 to 2010 previously.
But can it control its marketing expenses?
The big question when it reports earnings on Feb. 8 is whether Groupon has reined in its marketing expenses. Those costs stood at around 55% of its net revenues for January to September 2011. Groupon leads the daily-deal market and shares this space with players such as LivingSocial and Google (GOOG) Offers.
Experts say now is the ideal time for the social media giant to go public.
By Olivia Oran
Facebook is edging closer to its eagerly anticipated IPO, according to The Wall Street Journal, which says the social networking phenomenon may file its IPO documents on Wednesday. Experts say now is the perfect time for Facebook to start out on its IPO path.
"We expected them to file in the third to fourth week of January because they closed their prior quarter Dec. 31," said Sam Hamadeh, the CEO of research firm PrivCo. "Now they get a full 120 days runway to take off with the IPO without showing any other quarterly numbers and filing any amendments."
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Stocks drift lower and bonds are hit as investors await the Fed. Prepare for higher volatility this week.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The stock market welcomed the new trading week with a mixed session that saw relative strength among large-cap stocks, while high-beta names underperformed. The Dow Jones Industrial Average (+0.3%) and S&P 500 (-0.1%) finished near their flat lines, while the Nasdaq Composite and Russell 2000 both lost 1.1%.
Equities began the day on a cautious note amid continued concerns regarding the strength of the global economy. Over the weekend, China reported its first decline ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|